Erytech Pharma S.A. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.96
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.30
|
0.00
|
0.30
|
100.00%
|
|
2022-12-31
|
-0.33
|
0.00
|
0.33
|
100.00%
|
|
2022-09-30
|
-0.35
|
-0.35
|
0.00
|
-0.77%
|
|
2022-06-30
|
-0.37
|
0.30
|
0.67
|
179.65%
|
|
2022-03-31
|
-0.37
|
0.00
|
0.37
|
100.00%
|
|
2021-12-31
|
-0.43
|
-0.39
|
0.04
|
10.28%
|
|
2021-09-30
|
-0.59
|
-0.64
|
-0.05
|
-7.71%
|
|
2021-06-30
|
-0.72
|
-0.78
|
-0.06
|
-7.81%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.05
|
|
2021-12-31
|
-2.46
|
|
2020-12-31
|
-4.76
|
|
2019-12-31
|
-3.71
|
|
2018-12-31
|
-2.40
|
|
2017-12-31
|
-2.38
|